These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7758803)

  • 1. Molecular characterisation of novel receptors for PACAP and VIP.
    Lutz EM; Mendelson S; West K; Mitchell R; Harmar AJ
    Biochem Soc Trans; 1995 Feb; 23(1):83S. PubMed ID: 7758803
    [No Abstract]   [Full Text] [Related]  

  • 2. Chimaeric VIP2/PACAP receptors reveal that agonist pharmacology but not signal transduction is determined by extracellular domain 1.
    Lutz EM; MacKenzie CJ; Morrow J; Mitchell R; Bennie J; Carroll S; Clark E; Harmar AJ
    Ann N Y Acad Sci; 1996 Dec; 805():574-8. PubMed ID: 8993442
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of cyclic AMP and inositol phosphate production in rat prostatic cultures by VIP/PACAP, ATP, and carbachol: role in prostatic proliferation.
    Guijarro LG; Juarranz MG; Marinero MJ; Pajuelo L; Carmena MJ; Prieto JC
    Ann N Y Acad Sci; 1996 Dec; 805():723-8. PubMed ID: 8993468
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM; Carmena MJ; Carrero I; Cavallaro S; Roman F; Hueso C; Travali S; Lopez-Fraile N; Guijarro LG; Prieto JC
    Endocrinology; 1996 Jul; 137(7):2815-22. PubMed ID: 8770902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and coupling of PACAP/VIP receptors in cortical neurons and type I astrocytes.
    Grimaldi M; Cavallaro S
    Ann N Y Acad Sci; 2000; 921():312-6. PubMed ID: 11193842
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs.
    Dickinson T; Fleetwood-Walker SM; Mitchell R; Lutz EM
    Neuropeptides; 1997 Apr; 31(2):175-85. PubMed ID: 9179871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional type II VIP-PACAP receptors in human airway epithelial-like cells.
    Lindén A; Yoshihara S; Cardell LO; Kaneko T; Stjärne P; Nadel JA
    Peptides; 1997; 18(6):843-6. PubMed ID: 9285933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor.
    Delporte C; Poloczek P; de Neef P; Vertongen P; Ciccarelli E; Svoboda M; Herchuelz A; Winand J; Robberecht P
    Mol Cell Endocrinol; 1995 Jan; 107(1):71-6. PubMed ID: 7796937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/Lutein cells via two receptor subtypes.
    Gräs S; Hedetoft C; Pedersen SH; Fahrenkrug J
    Biol Reprod; 2000 Jul; 63(1):206-12. PubMed ID: 10859261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP).
    Morrow JA; Lutz EM; West KM; Fink G; Harmar AJ
    FEBS Lett; 1993 Aug; 329(1-2):99-105. PubMed ID: 8394834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion.
    Inagaki N; Kuromi H; Seino S
    Ann N Y Acad Sci; 1996 Dec; 805():44-51; discussion 52-3. PubMed ID: 8993392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple receptors for PACAP and VIP.
    Harmar T; Lutz E
    Trends Pharmacol Sci; 1994 Apr; 15(4):97-9. PubMed ID: 7912462
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun.
    Delgado M; Munoz-Elias EJ; Kan Y; Gozes I; Fridkin M; Brenneman DE; Gomariz RP; Ganea D
    J Biol Chem; 1998 Nov; 273(47):31427-36. PubMed ID: 9813054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.